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Inflammatory and innate immune responses triggered by pathogen-associated and other 22 
danger-associated signals emerging during infections, results in the activation of cytosolic 23 
inflammasomes . The nod-like receptor pyrin domain containing 3 (NLRP3) is one of the 24 
inflammasomes mediating such responses through the activation of caspase-1, which 25 
increases the production and release of pro-inflammatory cytokines, such as IL-1β and IL-18 26 
and induces programmed cell death through pyroptosis., NLRP3 is thought to play a crucial 27 
role in  the underlying inflammatory responses  in many lifestyle related  chronic diseases. 28 
Consequently, research on the NLRP3 inflammasome has expanded dramatically in recent 29 
years. Although several studies have investigated the role of NLRP3 activation in chronic 30 
kidney disease (CKD), few studies have evaluated strategies to modulate its activation by 31 
means of interventions using bioactive compound present in food. This review discusses 32 
bioactive compounds that have been shown to influence NLRP3 in experimental models of 33 
renal disease, and in CKD. It  discusses how these compounds could potentially dampen 34 
NLRP3 associated inflammatory burden, as part of nutritional strategies to prevent and treat 35 
CKD and its complications.  36 
Keywords: bioactive compound, chronic kidney disease, inflammation, inflammasome, 37 
oxidative stress. 38 
 39 
  40 
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1. Introduction 41 
Inflammasomes are large cytoplasmic multiprotein complexes belonging to the innate 42 
immune system, that are formed in response to stimuli from pathogen-associated molecular 43 
patterns (PAMPs) and danger-associated molecular patterns (DAMPs), emerging during 44 
infections, tissue damage or cellular stress. These signals are sensed by pattern recognition 45 
receptors (PRRs) and lead to activation of inflammasome mediated caspase-dependent 46 
inflammatory responses, through the release of cytokines and induction of cell death by 47 
pyroptosis (a form of caspase induced inflammatory programmed cell death). To date, the 48 
following inflammasomes have been reported: leucine-rich repeat (LRR)-containing proteins, 49 
nucleotide-binding oligomerization domain (NOD) (also known as NOD-like receptors (NLRs), 50 
such as NLRP1, NLRP3, and NLRC4); absent-in-melanoma 2 (AIM2); and other similar 51 
complexes, such as NLRP2, NLRP6, NLRP7, NLRP12 and IFI16, are also considered 52 
inflammasomes (Guo et al., 2015; Kelley et al., 2019).- Might be useful to tabulate these? 53 
Inflammasomes mediate activation of Caspase-1, which cleaves pro-interleukin-1β (pro-54 
IL-1β) and pro-IL-18 into their mature IL-1β and IL-18 forms. This in turn, leads to a complex 55 
network of cellular reactions initiating local and systemic inflammatory reactions (Boaru et 56 
al., 2015; Afonina et al., 2017). Four inflammasomes (NLRP1, NLRP3, AIM2, and pyrin) 57 
contain an adaptor protein termed apoptosis-associated speck-like protein containing a 58 
caspase-recruitment domain (ASC), which leads to the recruitment of pro-caspase-1 (Kelley 59 
et al., 2019).  60 
The best characterized inflammasome is the Nod-like receptor pyrin domain containing 3 61 
(NLRP3), which  responds to pathogen ingress, or damage signals  arising from endogenous  62 
from tissue injury (Guo et al., 2015). NLRP3 activation induces cell death  via caspase 1 63 
dependent pyroptosis, 1. In this process, caspase 1 induces generation of plasma membrane 64 
pores that facilitate osmolytic cell death and the release of IL-1β (Swanson et al., 2019; Li et 65 
al., 2019; Broz & Dixit, 2016; Carty et al., 2019).  66 
NLRP3 is primarily associated with host immune defenses against infections provoked by 67 
viruses, bacteria or fungi. However NLRP3 is also linked to the development of several 68 
chronic life style related diseases characterized by persistent inflammation, such as 69 
Alzheimer disease, gout, atherosclerosis, diabetes, autoinflammatory diseases, arthritis, 70 
obesity and CKD (Zamani et al., 2019; Masood et al., 2015; Guo et al., 2017; Kim et al., 2018; 71 
El-Horany et al., 2017). 72 
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Persistent low-grade inflammation is a prominent feature of the uremic phenotype and 73 
both a driver of cardiovascular diseases (CVD) (Mafra & Fouque, 2015; Farage et al., 2016; 74 
Jankowska et al., 2017; Koppe et al., 2019) and a common feature of the diseasome of 75 
ageing (Kooman et al., 2017). Thus, understanding the mechanisms and interplay between 76 
these complications in CKD patients, may help the development of therapeutic strategies to 77 
reduce mortality and improve the quality of life for these patients (Granata et al., 2015; Ding 78 
et al., 2015; Hautem et al., 2017). One non-pharmacological strategy proposed for clinical 79 
use to reduce inflammation in in CKD patients has been interventional nutrition, using 80 
bioactive nutraceuticals (Saldanha et al., 2016; Martins et al., 2018; Alvarenga et al., 2018; 81 
Mafra et al., 2019a; Alvarenga et al., 2019). The review will discuss the rationale  and 82 
evidence underpinning such a nutraceutical based intervention in CKD, specifically with 83 
reference  to the NLRP3 inflammasome. 84 
  85 
2. Mechanisms of NLRP3 inflammasome activation 86 
NLRP3 is a member of the Nod-Like Receptor (NLR) family, that is functionally active 87 
within the innate immune system (Chen et al., 2011; Kim et al., 2017). It possesses a C-88 
terminal leucine-rich repeat protein-3; intermediate NOD domain (NACHT domain), which 89 
has ATPase activity; a variable N-terminal pyridine domain (PYD) and ASC adapter protein 90 
(protein associated with apoptosis of the adapter molecule containing a CARD - caspase 91 
activation and recruitment domain), which harbors the PYD and CARD domains (Yang et al., 92 
2019; Kim et al., 2017; Gao et al., 2016). NLRP3 is expressed primarily in  a range of tissues ( 93 
principally the lungs, liver, kidney, colon, skin, eyes and ovaries), and in immune cells ( such 94 
as neutrophils, macrophages, Th2 cells, monocytes, primary keratinocytes (PK), HaCaT cells 95 
derived from keratinocytes, primary mast cells (MS), granulocytes and B cells) (Chen et al., 96 
2011).  97 
NLRP3 can be activated by molecular patterns associated with pathogens (PAMPs) and 98 
molecular patterns associated with damage (DAMPs) (Swanson et al., 2019). Among factors 99 
involved in NLRP3 activation are toxins, or environmental irritants, which cause lysosomal 100 
disruption (Kelley et al., 2019). Microbes, extracellular ATP, RNA viruses, potassium efflux 101 
and calcium influx may also act as activators of NLRP3 (Gaidt & Hornung, 2018). In addition, 102 
a priming signal occurs through two pathways (i) on toll-like receptors (TLRs) activated by 103 
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microbes or (ii) on TNF and IL-1 receptors, which lead to the activation of the transcription 104 
factor nuclear factor kappa B (NF-κB), which upregulates the expression of NLRP3 (Kelley et 105 
al., 2019). 106 
Activation of NLRP3 is through ubiquitination via DHX33 (cytosolic double-stranded RNA 107 
sensor, a member of DExD/H-box helicase family), where NLRP3 is modified by specific 108 
ubiquitin chains, mainly lysine 63(K63) (Kattah et al, 2017; Bednash et al, 2016). TRIM33 (a 109 
member of the tripartite motif and E3 ubiquitin (Ub) ligases) binds DHX33 and induces the 110 
K63-polyubiquitination, which is essential to form the DHX33-NLRP3 inflammasome 111 
complex, resulting in to NLRP3 activation (Kattah et al, 2017).  112 
When NLRP3 is activated, the PYD, present in the inflammasome structure, undergoes 113 
oligomerization, which triggers the recruitment and nucleation of the apoptosis-associated 114 
speck-like protein containing a CARD (ASC) adapter protein (Li et al. 2019). Thus, an 115 
association between the NLRP3 inflammasome and the ASC protein adapter, generates the 116 
formation of a complex structure (Tsuchiya, 2020). This structure initiates autocatalytic 117 
activation of caspase-1, which cleaves cytokine precursors pro-IL1β and pro-IL18, generating 118 
their active form, IL1β and IL18 (Li et al. 2019; Tsuchiya, 2020; Chan & Schroder, 2020). 119 
 Additionally, recent studies have demonstrated that the NLRP3 inflammasome can be 120 
regulated by the transcriptional control of gene expression, via microRNAs (miRNAs) (Zamani 121 
et al., 2019; Kim et al., 2017). It is also responsive  to mitochondrial dysfunction, which leads 122 
to ROS production that activates the phosphorylation of p65 NF-κB, thus inducing NLRP3 123 
(Bauernfeind et al., 2016; Liang et al., 2017; Swanson et al., 2019). Some molecular signaling 124 
mechanisms that have been shown to activate the NLRP3 inflammasome are illustrated in 125 
Figure 1. 126 
 127 
3. Other substances: Negative regulation of NLRP3 128 
After the primary goal of the inflammatory response is achieved, the organism must 129 
restore normal tissue homeostasis, hence resolution of the inflammatory response should 130 
occur (Bauernfeind et al., 2012; Zamani et al., 2019). Additionally, it is important to 131 
understand the negative regulatory pathways of the inflammasome, as they may provide 132 
tools for more potent therapeutic strategies for the treatment of inflammatory diseases 133 
related to the activation of the NLRP3 inflammasome (Yang et al., 2019). 134 
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The negative regulation of NLRP3 occurs through type I interferons (IFN-α and IFNβ), 135 
which are able to inhibit the activity of the NLRP3 inflammasome. To limit the initiation of 136 
NLRP3, type I IFNs influence the availability of the precursor forms of IL-1α and IL-1β by 137 
reducing their expression levels (Guarda et al., 2009; Guarda et al., 2011). Type I IFNs are 138 
involved in the activation of inducible nitric oxide synthase (iNOS), which in turn generates 139 
nitric oxide (NO). iNOS depletion leads to inhibition of NO production, which resulst in 140 
accumulation of dysfunctional mitochondria ( a hallmark of age related loss of physiological 141 
function, in keeping with CKD being a disease of accelerated ageing) and increase in IL-1β 142 
production and caspase-1 activation (Mao et al., 2013). In this context, when iNOS is 143 
activated and there is production of NO, mitochondrial function is stabilised  NLRP3 activivty 144 
is inhibited (Mao et al., 2013; Sutterwala et al., 2014). 145 
Furthermore, the activation of antioxidant enzymes, especially heme oxygenase, can 146 
inactivate NLRP3 by inhibiting the expression of the ROS-sensitive thioredoxin-interacting 147 
protein (TXNIP). The most widely accepted pathway for this inhibition is via the activation of 148 
nuclear factor erythroid 2-related factor 2 (Nfr2) cytoprotective responses. This is an 149 
important transcription factor for the regulation of cellular antioxidant defences (Xiaoyu et 150 
al., 2017) that play a significant role in chronic lifestyle related diseases, where systemic 151 
expression of Nrf 2 is typically diminished (Stenvinkel et al., 2019; Arefin et al 2020 Nrf2 in 152 
early vascular ageing: calcification, senescence and therapy Clin Chim Acta. 2020 Feb 22. pii: 153 
S0009-8981(20)30089-9. doi: 10.1016/j.cca.2020.02.026). Consequently, when NLRP3 154 
inflammasome function is dysregulated, it is observed in the context of a range of 155 
morbidities, including   CKD, chronic inflammatory disorders , depression, colorectal cancer 156 
and metabolic disorders  (Inserra et al., 2018; Chen et al., 2017). 157 
 158 
4. Chronic kidney disease and NLRP3 inflammasome 159 
The progression of CKD is closely related to levels of persistent inflammation and 160 
oxidative stress (Zoccali et al., 2017). CKD is characterized by increase in ROS production and 161 
impairment of the antioxidant responses, including a reduction in the expression of Nrf2 and 162 
increase in the expression of NF-κB expression,  and consequential  overexpression of pro-163 
inflammatory  cytokines (Mihai et al., 2018; Pedruzzi et al., 2012; Leal et al., 2015; Jankowska 164 
et al. 2017).  165 
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NLRP3 has been described as a promising candidate in mediating the inflammatory 166 
response in CKD, where cellular injury and inflammation coexist (Vilaysane et al., 2010; Ben 167 
et al., 2018; Mulay, 2019). Consequently, renal inflammation and fibrosis activate several 168 
NLRP3 agonists (Gong et al., 2016; Hutton et al., 2016). The renal NLRP3 exerts its’ effects via 169 
activation  of both the canonical regulation of caspase 1 pathway, with IL-1β and IL-18 170 
secretion leading to GSDMD cleavage and consequent cellular pyroptosis and,  by the non-171 
canonical route of activation of alternative caspases, such as caspase -4, -5 and -11. 172 
Epithelial-mesenchymal transition, fibrosis and cell death are also intimately involved in this 173 
process (Masood et al., 2015; Darisipudi & Felix Knauf, 2016; Komada et al., 2019). 174 
Animal and in vitro studies have shown a consistent link between NLRP3 function, 175 
mitochondrial damage and apoptosis in renal cells, leading to increased expression of IL-18 176 
and IL-1β (Guo et al., 2017; Kim et al., 2018; Ding et al., 2016; Szeto et al., 2017). A study of 177 
renal tubule interstitial lesions, for example,  has shown that the more severe the lesion, the 178 
greater the cellular expression of IL-1β, TLR-4 and NLRP3 mRNA expression, in keeping with 179 
the above hypothesis. Moreover, NRLP3 protein was expressed in greater amounts in cells 180 
with the highest degree of injury (Tashiro et al., 2016).    Accordingly, Vilaysane et al. (2010)  181 
have reported that NLRP3-/- mice displayed less tubular injury, attenuation of the 182 
inflammatory process, decreased caspase-1 activation and inhibition of IL-1β and IL-18 183 
maturation. Furthermore, in tissue from human renal biopsies from patients with diabetic 184 
nephropathy, increased expression of NLRP3 mRNA  has been reported to correlat with renal 185 
function (Vilaysane et al., 2010).  186 
Increased expression of NLRP3 mRNA and serum IL-1β 187 
level have been observed in CKD (Granata et al. 2015; El-Horany et al., 2017), which   can be 188 
interpreted as being  a consequence of  hyperglycemia,  oxidative stress and/or pathogenic 189 
mechanisms (Qiu & Tang, 2016). It is worth noting that uremic toxins, such as IS, indole 3-190 
acetic acid (IAA), TMAO and p-cresyl sulphate (p-CS), are generated by the gut microbiota 191 
and contribute to the activation of inflammatory responses and mitochondrial dysfunction 192 
(Wong et al., 2014; Sogawa et al., 2018; Wakamatsu et al., 2018; Li et al., 2019; Mafra et al., 193 
2019b). In support of this thesis, Chin et al. (2017) have observed a positive regulation of 194 
NLRP3, IL-1 and IL-18 in by indoxyl sulfate (IS), which contributed to myocardial apoptosis in 195 
nephrectomized rats. Recently El-Deeb et al., (2019)  have observed that trimethylamine N-196 
oxide (TMAO) can activate NLRP3 indirectly,  because it induces oxidative stress and triggers 197 
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ROS/NLRP3 signaling, resulting in the release of inflammatory cytokines in CKD patients. 198 
However, the pathway of inflammasome activation through specific PAMPs and DAMPs in 199 
the gut remains largely unknown.  It is possible that inflammatory porcesses are also 200 
trigerred by microbial ingress into the circulation via a leaky gut (O'Toole, P.W. and Shiels, 201 
P.G. The role of the microbiota in sedentary life style disorders and ageing: Lessons from the 202 
animal kingdom.J Intern Med. 2020 Jan 19. doi: 10.1111/joim.13021 203 
Poore, G. D. et al. Nature https://doi.org/10.1038/s41586-020-2095-1 (2020)).  204 
In toto, as NLRP3 appears to be involved in the pathogenesis of CKD, it may constitute a 205 
therapeutic target for prevention of CKD development and progression  (Anders et al., 2016; 206 
Foresto-Neto et al., 2018). 207 
 208 
5 Nutritional strategies to modulate the NLRP3 inflammasome 209 
Bioactive compounds are substances present in food, such as vegetables and fruits that have 210 
beneficial effects on health (Liu, 2013). Diverse bioactive nutrients have been applied as part 211 
of preventive and/or therapeutic nutritional strategies to tackle non-communicable diseases 212 
( NCDs), such as diabetes mellitus, hypertension, CVD, CKD and cancer (Liu, 2013). In this 213 
context, several studies have found positive effects for bioactive compounds in modulating 214 
inflammation and oxidative stress (Saldanha et al., 2016; Martins et al., 2018; Alvarenga et 215 
al., 2018; Mafra et al., 2019; Alvarenga et al., 2019). It is thought that these effects – at least 216 
in part - could be attributed to these bioactive compounds mitigating harmful effects  217 
associated with  inflammasome-related components in disease (Chuang et al., 2014). These 218 
observations are now discussed in detail with specific reference to individual  bioactive 219 
compounds.. 220 
  221 
5.1 Catechins 222 
Catechins are polyphenols present in food, such as apples, blueberries, gooseberries, grape 223 
seeds, kiwi, strawberries, green and black tea, grape and cocoa. The antioxidant properties 224 
of polyphenols are mainly due to their redox properties, as they act as reducing agents, 225 
hydrogen donors and free oxygen suppressors (Grzesik et al., 2018). Correspondingly, a 226 
number of groups have demonstrated salutogenic effects for catechins in pre=clinical 227 
models of disease. For example,  Tsai et al. (2011)  have shown in an animal model of lupus 228 
that epigallocatechin-3-gallate (EGCG) - a refined catechin from green tea - prevented 229 
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impaired renal function and proteinuria, increased Nrf2 activity, reduced NF-kB activation 230 
and NLRP3 mRNA protein expression.  Furthermore, Jhang et al (2015)  have demonstrated 231 
in rats with gout (induced by monosodium urate),  that subcutaneous catechin injection 232 
reduced ROS production, secretion of IL-1β and the NLRP3 inflammasome activation.  233 
5.2 Cinnamaldehyde 234 
Cinnamaldehyde is one of the major bioactive compounds found in Cinnamomum 235 
Osmophloeum kaneh leaves. Cinnamaldehyde  has been reported to reduce the expression 236 
of pro-inflammatory mediators in LPS-activated macrophages, inhibiting the generation of 237 
ROS and reducing NF-κB activation (Ka et al., 2016; Su-Chen et al., 2018). Cinnamaldehyde  238 
can prevent the activation of pro-caspase 1 and pro-IL-1β, thus avoiding the final activation 239 
of NLRP3 (Su-Chen et al., 2018).  A number of groups have demonstrated that 240 
cinnamaldehyde  can counter the effects of inflammasome activation in a range of disease 241 
and injury models ( Qu et al.2019; Lee et al, 2018).  In a renal setting in particular,  it 242 
decreased albuminuria, glomerular sclerosis and peri-glomerular inflammation ( Ka et al., 243 
2016; Kang et al., 2016), via inhibition of NLRP3, diminution of  ROS  production and 244 
repressed activation of NF-κB and pro-inflammatory mediators (Ka et al., 2016). Additionally, 245 
in a murine model of fructose-induced metabolic syndrome, cinnamaldehyde  reduced 246 
cardiac oxidative stress and  attenuated the activation of NLPR3 and TGF-β, by inhibiting TLR-247 
mediated signaling (Kang et al., 2016). 248 
 249 
5.3 Curcumin 250 
Curcumin is a curcuminoid found in Curcuma longa (Zingiberaceae), known for its 251 
anti-oxidant and anti-inflammatory potential. Guglielmo et al. (2017)  have observed that 252 
LPS stimulated macrophages treated with curcumin decreased IL-1β secretion. In addition to 253 
this, curcumin may change S-glutathionylation critical to NLRP3 formation , thus limiting its 254 
capability  to contribute to pathogenesis per se (Guglielmo et al, 2017).  Other studies  have 255 
shown that curcumin administration decreases the activation of the inflammasome via 256 
TXNIP associated NLRP3 inflammasome activation (TXNIP / NLRP3). Not only does curcumin 257 
participate in the cleavage of caspase-1 but it reduces expression of both  inflammatory 258 
mediators IL-1β and TNF-α, (Ding et al., 2018; Li et al., 2015; He et al., 2018; Sun et al., 2017; 259 
Gong et al., 2018; Liu et al., 2018; Li et al., 2019; Zhang et al., 2019).). 260 
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Additionally, curcumin suppresses NLRP3 mediated inflammation through a number 261 
of distinct processes, including blocking potassium efflux from the cell and stimulation of  262 
ASC retention  thus preventing the formation of NLRP3 in mitochondria (Yin et al., 2018; 263 
Gong et al., 2015). Additionally, curcumin reverses the activation of  the purinergic 2X7 264 
(P2X7R) siRNA receptor, thus reducing NLRP3 expression and caspase-1 /IL-1β secretion 265 
(Kong et al., 2016).  266 
Pre-clinical models of systemic lupus erythematosus (SLE) and CKD have indicated 267 
reno-protective effects for curcumin. Female mice with SLE, supplemented with curcumin  at 268 
200 mg/kg/day for 8 weeks, presented  with decreased glomerular cell inflammation and 269 
decreased renal expression of inflammasome NLRP3 and caspase-1, in addition to decreased 270 
serum levels of IL-1β (Zhao et al., 2019). Supplementation with theracurmin (a curcumin 271 
analog with high bioavailability) at 100 mg/kg/day for 5 weeks showed attenuated 272 
proteinuria and heart damage in a mouse model of CKD. These observatiosn were 273 
accompanied by an  observed reduction in NLRP3 and mature IL-1β activation (Bugyei-Twum 274 
et al., 2016). Only one study  has shown the effects of curcumin supplementation in 275 
hemodialysis patients, where 2.5 grams of turmeric (95%curcumin) given 3 times per week 276 
over three months, was not able to decrease the mRNA expression of the NLRP3 277 
inflammasome, nor IL-1β. However, curcumin was able to reduce NF-kB trasncriptional 278 
expression and high sensitivity C-reactive protein (hsCRP) plasma levels (Alvarenga et al., 279 
2020).  These results suggest that curcumin may be a new therapeutic option to reduce 280 
inflammasome activation and protect against cardiovascular events in CKD (Bugyei-Twum et 281 
al., 2016; Zhao et al., 2019). 282 
 283 
5.4 Emodin 284 
Emodin is a bioactive compound present in rhubarb and oriental herbs, being the 285 
main active ingredient of the Chinese Qingyi decoction, and widely used to treat allergies 286 
and inflammation (Han et al., 2015). Some  pre-clinical studies have shown that emodin can 287 
modulate the NLRP3 activation pathway, thus decreasing the inflammatory response by 288 
attenuation of  IL-1β secretion,  so inhibiting the activation of the NLRP3 inflammasome (Han 289 
et al., 2015). Ye et al., (2019) have observed that emodin is effective in protecting the 290 
myocardium against ischemic injury. via prevention of  NLRP3-mediated pyroptotic cell 291 
death and  and attenuation of NLRP3 activation. Additionally, in a rat  model of pancreatitis, 292 
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emodin has been shown to inhibit NLRP3 signaling by blocking P2X7, thus inducing a 293 
reduction in IL-1β, IL-18 and myeloperoxidase plasma levels (Zhang et al., 2019). 294 
 295 
5.5 Ginsenoside 296 
Ginseng, a plant grown in East Asia and Northeast America, has long been used in 297 
traditional medicine. Ginseng is rich in ginsenoside, a steroidal saponin. belonging to a group 298 
of compounds, the  ginsenosides, comprising  Rb1, Rb2 and Rd, 20 (S) -Rg3 and 20 (R) -Rg3 299 
(Yoon et al., 2015). Ginsenoside Rg3 exhibits cyto-protective and  physiologically salutogenic 300 
properties, such anti-inflammatory, antioxidant, anti-obesity activities (Kim et al., 2014). 301 
Several experimental studies  have shown that ginsenosides hold promise for suppressing 302 
activation of various types of inflammasomes, including NLRP3. Consistent with this, 303 
ginsenosides can also inhibit caspase-1 activation and reduce IL-1β and IL-18 expression (Yi, 304 
2019). Furthermore, the salutogenic propertie attributed to ginsenoside Rg1 include  305 
increaseing expression of superoxide dismutase (SOD) and peroxisome proliferator-activated 306 
receptor-alpha (PPARα), thereby stimulating the oxidation of beta fatty acids, and regulation 307 
of  inflammatory processes by inhibiting NLRP3, IL-1β and IL-18 (Xu et al., 2018), possibly via 308 
inhibition of P2X7 receptor activation and NF-κB (Han et al., 2018; Li et al., 2018). Another 309 
mechanism has also been proposed for Rb1 ginsenoside, via stimulation of Nfr2, thereby 310 
reducing the interaction of the NLRP3 inflammasome with TXNIP, thus imhibiting pro-IL-1B 311 
maturation (Chen et al., 2016; Zhai et al., 2018). 312 
 313 
The non-saponin fraction of ginsenoside can also modulate the action of the  NLRP3 314 
inflammasome, by inhibiting NLRP3 signaling and preventing pro-IL1β maturation. by 315 
inhibition of TLR4-MyD88-NF-κB interaction ( Byung-Cheol et al. 2017;Ahn et al., 2019).  316 
 317 
5.6 Purple sweet potato 318 
The anthocyanin giving purple sweet potato its colour, is a natural antioxidant and 319 
anti-inflammatory compound  with geroprotective (anti-ageing) properties that may be 320 
beneficial in slowing and preventing the progression of CKD (Shan et al., 2014; Sun et al., 321 
2015; Sun et al., 2019).  Correspondingly, it It has been reported to retard glucose-induced 322 
endothelial senescence via inhibition of  the NLRP3 inflammasome, activation of autophagy,  323 
and attenuation of ROS production (Sun et al., 2015; Sun et al., 2019).  324 
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 Notably, Shan et al., (2014) have observed that rats with liver inflammation receiving 325 
purple sweet potato supplementation  displayed reduced expression of the renal NLRP3 326 
inflammasome,with concomitant inhibition of ASC, caspase-1 and IL-1β. Additionally, 327 
inhibition of IKKβ activation and NF-κB expression was reported. In the same animal model, 328 
purple sweet potato blocked hepatic oxidative stress by increasing the level of NAD+ in the 329 
endoplasmic reticulum. This lead to suppression of the nuclear translocation of NF-κB p65 (a 330 
structural protein of NF-κB), with consequent decreased activation of NLRP3 (Wang et al., 331 
2017). This is also consistent with geroprotective activity ascribed to purple sweet potato, as 332 
NAD+ is a major substrate for the sirtuin family of proteins, which regulate the epigenetic 333 
landscape of ageing in response to metabolic stress ( reviewed in Shiels et al Nat. Rev Neph 334 
2017). 335 
 5.7 Quercetin 336 
Quercetin is a polyphonic flavonoid found in onion, garlic, apple and red fruits. It 337 
possesses anti-oxidant and anti-inflammatory capabilities. Moreover, quercetin protects 338 
mitochondrial integrity and inhibits mitochondrial ROS release through its action on the  339 
NLRP3 inflammasome (Xue et al., 2017), NF-κB expression and the levels of IL-1β and IL-18 340 
(Liu et al., 2018). Quercetin (and Ascorbic acid) may also diminsih inflammation by inhibiting 341 
TXNIP, which is one of the components that activates NLRP3 (Wu et al., 2014; Choe et al., 342 
2017). In pre-clinical models of arthritis, quercetin has been reported to reduce post 343 
transcriptional expression of NLRP3, caspase-1 and IL-1β (Yang et al, 2018). Ding et al. (2018)  344 
have shown that dihydroquercetin supplementation modulates the overproduction of ROS 345 
and decreases NLRP3 activation in rats with diabetic nephropathy, resulting in 346 
nephroprotection and improvement in glucose and lipid control. 347 
 348 
5.8 Resveratrol 349 
Resveratrol, a powerful geroprotective compound, belonging to the polyphenol 350 
family,  is found in wine, grapes and peanuts (Zhang et al., 2017).  It is a Sirtuin 1 agonist with 351 
a proven capacity for mitigating the effects of cellular stress. Studies have shown that 352 
resveratrol plays an important role in controlling inflammatory and antioxidant responses. 353 
One of its modes of action is through modulation of the NLRP3 system (He et al., 2017; Ding 354 
et al., 2019). Resveratrol  can block the  transcriptional expression of NLRP3, caspase 1, IL-1β 355 
and IL-18, as well as  that of their cognate proteins (Dong et al., 2015; Sui et al., 2016; Wu 356 
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& Huang, 2017). Resveratrol inhibits the expression of NLRP3 and cytokines by several 357 
mechanisms. Firstly,  via blockade of the NLRP3 signaling pathway which leads to inhibition 358 
of inflammatory processes and  production of mature cytokines (Misawa et al., 2015). 359 
Secondly, through the reduction of mitochondrial ROS production, by blocking TXNIP protein 360 
expression (Jiang et al., 2016; Li et al., 2016; Zou et al., 2018). 361 
Misawa et al. (2015) have shown that resveratrol inhibits the accumulation of tubulin 362 
acetylates responsible for mitochondrial damage and consequent induction of NLRP3 363 
Consequently, tubulin acetylate inhibition by resveratrol leads to inhibition of ASC on the 364 
mitochondria and NLRP3 inactivation. Notably, inhibition of mitochondrial damage impairs 365 
the assembly of inflammasome (Chalons et al., 2018).  366 
Thirdly, via  Syk dependent suppression of IL-1β secretion  (Chung et al., 2019).  367 
 368 
This mechanistic understanding is supported by a number of observations in pre-369 
clinical models ( including  of CKD), demonstrating  a capacity for resveratrol to mitigate 370 
NLRP3 mediated ischaemia- reperfusion damage in the rat intestine (Zhao et al., 2018), 371 
promotion of  autophagy and in renal cells (Chang et al., 2015;  Lin et al. 2017; Chen et al., 372 
2019). 373 
 374 
5.9 Silybin 375 
Silybin is the major bioactive compounds found in silymarin, extracted from the 376 
medicinal plant Silybummarianum.  IN a range of in vitro and in vivo experimental systems, 377 
silybin  has been shown to attenuat the production of IL-1β and TNF, and decreases the 378 
recruitment of inflammatory cells, including macrophages, T cells, THP-1 cells and 379 
neutrophils (Tian et al., 2017; Zhang et al., 2018).  The mechanistic basis for these 380 
observations has been attributed to an inhibitory effect for silybin on NF-κB and NLRP3 381 
signaling (Tian et al., 2017; Zhang et al., 2017). Silybin modulates the NLRP3 inflammasome 382 
by blocking the TLR4 / NF-κB pathway and inhibits NLRP3 by reducing TXNIP expression, pro-383 
caspase 1 activation, and IL-1β release (Zhang et al., 2018; Matias et al., 2019). In addition to 384 
these, silybin elevates  the expression of Nrf2 and HO-1 thus enhancing physiological 385 
resilience.(Greaney et al., 2016; Yuan et al., 2017). 386 
 387 
5.10 Sulforaphane 388 
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Sulforaphane, a bioactive compound found in cruciferous vegetables like broccoli, 389 
Brussel sprouts, cauliflower, cabbage, which  has a range of geroprotective and salutogenic  390 
properties, including influencing the assembly and activation of NLRP3 (Yang et al., 2018). 391 
Sulforaphane  can act as an antioxidant through the suppression of the production of 392 
mitochondrial ROS, thus depressing NLRP3  expression (Lee et al., 2016). Importantly, 393 
sulforaphane is an Nrf2 agonist, in addition to upregualting the expression fo a battery of 394 
other cytoprotective genes, including   quinone oxidoreductase-1, HO-1, SOD1 and GPX1 395 
(Dong et al., 2016; Li et al., 2019). The result of such activities is a consequential inhibition of  396 
p20 caspase-1, p17 IL-1β and ASC, which are primary components for the formation of the 397 
NLRP3 inflammasome (Li et al., 2019; Li et al, 2018). 398 
Sulforaphane has also been reported to have anti-oncogenic properties (ref), though 399 
as Nrf 2 is specifically up-regulated in a range of tumours (and not systemically in cancer) . 400 
and sulforaphane is an Nrf 2 agonist, its  clinicnal use must be treated with caution, until 401 
hermetic dosing levels are determined ( ref) 402 
 403 
5.11 Procyanidin 404 
Procyanidins are flavonoids found in red fruits and red wine that inhibit the activation of 405 
NLRP3 by inactivating caspase-1 and secretion of IL-1β, decreasing ROS and the transcription 406 
of activator protein-1 (AP-1) (Yang et al., 2014). 407 
Procyanidins can also inhibit the activation of NLRP3 by inactivating  the NF-κB signaling 408 
pathway (Yang et al., 2014; Liu et al., 2017). The proposed mechanism is thought  to be  via 409 
inhibition of p65 nuclear expression and DNA binding, resulting in the transcriptional 410 
repression of target genes, such as COX2, iNOS and production of IL-6, IL-18, IL-1β and NO 411 
(Martinez-Micaelo et al., 2015). 412 
 Furthermore, procyanidins decrease the ASC and caspase-1 signalling, which 413 
consequently leads to less activation of NLRP3 (Jiang et al., 2018). Procyanidins have been 414 
shown to  attenuate experimental colitis in vivo, by suppressing NF-κB and NLRP3 signaling 415 
expression in colon tissue in mice (Chen et al, 2018). A reduction in NLRP3 activation and 416 
serum IL-1β and IL-18 production was  also found in rats with lupus nephritis receiving 417 
procyanidin supplementation for 8 weeks (100 mg/kg) (He et al., 2018). 418 
 419 
5.12 Probiotics  420 
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Probiotics are natural or genetically modified microorganisms, capable of  conferring a 421 
health benefit when established in the human gut (FAO/WHO, 2017). Among many 422 
suggested benefits, probiotics influence the expression of inflammasomes and modulate gut 423 
inflammation (Wang et al., 2016). Dolpady et al. (2016)  have shown that rats receiving 424 
probiotic supplements (Bifidobacteriaceae, Lactobacillaceae and Streptococcus 425 
thermophilus), presented  with reduced IL-1β expression and reduced differentiation of Th1 426 
and Th17 cells in the intestinal mucosa. Supplementation of Lactobacillus plantarum for 8 427 
weeks reduced LPS-induced intestinal inflammation in rats (Vilahur et al., 2015). Thus, 428 
stabilization and regulation of gut microbiota may lead to a reduction in inflammatory 429 
reactions related to the gut pathologies. In rats, probiotics (Streptococcus thermophilus and 430 
thermophiles; Lactobacillus bulgaricus, lactis, acidophilus, reuteri and plantarum; 431 
Bifidobacterium lactis)   have also been reported to decrease hypothalamic expression levels 432 
of IL-1β, NLRP3, caspase-1 and NF-kB (Avolio et al, 2019) with salutogenic benefits.. 433 
 434 
5.13 Polyunsaturated fatty acids 435 
Polyunsaturated fatty acids (PUFAs) include agents such as omega-3; α-linolenic acid; 436 
Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA). The dietary sources of these 437 
nutrients are rapeseed oil, flaxseed oil, salmon, mackerel, sardines, sunflower oil, grape seed 438 
oil and corn oil. PUFAs have an important anti-inflammatory and antioxidant capabilities 439 
(Jarmakiewicz-Czaja et al, 2020). 440 
Omega-3, as well as EPA and DHA, seems to inhibit expression of  NLRP3, by activation of 441 
G protein-coupled receptor 120 (GPR120) and GPR40, via binding to NLRP3 (Yan et al, 2013; 442 
Williams-Bey et al, 2014). Apparently, a downstream scaffold protein of GPR40, β-Arrestin-2 443 
(ARRB2), activates the interaction of GPR120 and GPR40 with NLRP3 and inhibits 444 
inflammation (Yan et al, 2013; Lin et al, 2017).  445 
In addition to this, DHA inhibits the inflammasome-priming step, by suppressing the 446 
nuclear translocation of NF-κB and interfering with TLR4 signal transduction (Martínez-447 
Micaelo et al, 2016). In fact, in hepatocytes, dietary PUFAs (DHA) regulate the expression and 448 
activity of NLRP3 inflammasome through direct inhibition of NF-κB (Sui et al, 2016). De Boer 449 
et al. (2016), in a study with macrophages in obese adipose tissue,  have shown that omega-450 
3 was able to decrease transcriptional expression of Caspase 1, IL-1β and IL-18. Additionally, 451 
omega-3 decreased the phosphorylation of p65 NF-kB and expression of NLRP3 452 
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inflammasome gene  thus doing what?……. Furthermore, resolvins, which are DHA 453 
metabolites- (e.g. resolvin D1 (RvD1), and 17S-hydroxy DHA (17SHDHA)),  also have potent 454 
anti-inflammatory effects. They have been demonstrated to prevent 455 
hyperhomocysteinemia-induced formation of NLRP3 inflammasomes, ASC, caspase-1 and 456 
interleukin-1 production.  Moreover, in vivo, DHA metabolites have been observed to  inhibit 457 
podocyte NLRP3 inflammasome formation and activation (Li et al, 2017). 458 
In a study with mice receiving diets containing palm oil, fish oil, echium oil (containing 459 
18:4 n-3), or borage oil (containing 18:3 n-6), dietary PUFAs  have been demonstrated  to 460 
inhibit inflammasome activation, decrease IL-1 β secretion and caspase-1 cleavage in 461 
response to NLRP3 inflammasome activators (Shen et al, 2017). 462 
Finally, a study with obese individuals has shown that 4g/day of fish oil supplements (EPA 463 
and DHA) reduced expression of adipose inflammatory genes including inflammasome-464 
associated IL-18 and IL-1β and circulating IL-18 levels (Lee et al., 2018). 465 
 466 
5.14 Other bioactive compounds  467 
Allicin, a bioactive compound of garlic, is able to inhibit the inflammatory activity of 468 
NLRP3 by suppression of oxidative stress. Allicin decreases ROS production, lipid 469 
peroxidation, and, consequently, activation of the NLRP3 inflammasome (Gao et al., 2019). 470 
Endothelial cells treated with dihydromyricetin, a natural flavonoid found in 471 
the Ampelopsis species japonica (known as peppervine), megalophylla, and grossedentata,  472 
showed inhibition of caspase-1 activation, maturation and release of  IL-1β and activation of 473 
NLRP3. The proposed mechanism  for these observations was suppression of ROS production 474 
via increased Nrf2 signaling (Hu et al., 2018). 475 
Olive leaf extracts suppress inflammation of placental tissues by inhibiting NF-κB p65 476 
protein expression and, consequently decreasing NLRP3 protein expression and pro-IL-1β 477 
(Kaneko et al., 2019). Piperine, the main bioactive component of pepper, was effective in 478 
inhibiting NLRP3 inflammasome and reducing serum IL-1β in mice with lupus nephritis (Peng 479 
et al., 2018).  480 
Some vitamins can also modulate the activation and expression of the NLRP3 481 
inflammasome. Rao et al. (2019)  have observed that  the vitamin D receptor may be a 482 
negative regulator of NLRP3. Apparently, the vitamin D receptor can bind NLRP3 and block 483 
the deubiquitination (cleave ubiquitin molecules from protein substrates) of NLRP3, leading 484 
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the NLRP3 inhibition. Paricalcitol, a vitamin D agonist, shown to be able to reduce the 485 
expression of TGF-β and the NLRP3 inflammasome in epithelial cells, is  associated with a 486 
down-regulation of NOX activity (Ko et al, 2019). Vitamin D3 can downregulate intracellular 487 
ROS and inhibit TXNIP and  the NOD-like receptor family, involved in NLRP3 inflammasome 488 
pathway activation (Lu et al, 2018).  Furthermore, calcitriol protects cells against oxidative 489 
stress and inflammation through inhibiting ROS-NLRP3-IL-1β signaling axis (Dai et al, 2019).  490 
 491 
All these observations relative to vitamin D biology are pertinent to renal disease, as the 492 
Vitamin D receptor controls expression of the anti-ageing gene klotho.  Klotho  is a co-493 
receptor with fibroblast growth factor receptor-1 and its FGF23 ligand that regulates renal 494 
phosphate and calcium reabsorption ( Kuro-o Nat Rev Neph 2019).  495 
 496 
 497 
Vitamin E seems is also involved with NLRP3 inflammasome pathway. In murine 498 
macrophages inflammasome activation, caspase-1 cleavage and IL 1β secretion have been 499 
reported to be  attenuated by gamma-tocotrienol treatment (Kim et al, 2016). Gamma-500 
tocotrienol may decrease the activation of NLRP3-inflammasome by change of the  501 
macrophage lipidome, as reduction of lysophospholipids, diacylglycerol and free arachidonic 502 
acid lead to the attenuation of TLR4-NFκB signaling axis activation, resulting in reduced 503 
NLRP3 inflammasome activation (Kim et al, 2018). Vitamin B6 also inhibits NLRP3-dependent 504 
caspase-1 missing word and secretion of mature IL-1β and IL-18 in LPS-primed macrophages 505 
(Zhang et al., 2016). 506 
 507 
5.15 Caloric restriction 508 
Caloric overload activates NLRP3 through mitochondrial damage, increased blood 509 
pressure and insulin resistance (Traba & Michael, 2017). Although caloric restriction may 510 
improve mitochondrial functioning and weaken the inflammasome (Traba & Michael, 2017; 511 
Bang et al., 2019), few studies involving caloric restriction have evaluated its effects on the 512 
formation and signaling of  the inflammasome (Bang et al., 2019). Fann et al. (2014)  have 513 
observed that intermittent fasting in mice leads to inhibition of NF-κB and NLRP3 activation 514 
and decreased plasma IL-1β and IL-18 concentrations. In healthy volunteers, Traba et al., 515 
(2015) have  observed that after a 24-hour fast there was a reduced activation of NLRP3 as 516 
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compared to the fed state. Finally, a study in rats  has shown that ketone bodies (β-517 
hydroxybutyrate and acetoacetate) formed during a low caloric diet, decreased the 518 
activation of NLRP3. In addition, ketone bodies reduced NLRP3-mediated production of IL-1β 519 
and IL-18 interleukin (Youm et al., 2015).  520 
6. Conclusion  521 
The NLRP3 inflammasome has a key role in processes leading to chronic inflammation, 522 
which is an inherent feature of many clifestyle related and other NCDs  including CKD. The 523 
internal uremic milieu activates NLRP3 and  pro-inflammatory cytokines by several 524 
mechanisms. There are many  naturally occcuring bioactive compounds, such as botanical 525 
polyphenols, that may influence the activation of the NLRP3 inflammasome.  Accumulating 526 
data suggest that a diet rich in bioactive compounds, or  the use of probiotics/  microbial 527 
biotherapeutics and caloric restriction could be promising strategies to decrease the 528 
activation of the NLRP3 inflammasome (Figure 2). However, to the best of our  current 529 
knowledge, few experimental CKD studies  have shown effectiveness for the clinical use of  530 
bioactive compounds as a means to control inflammation (Table 1). Further studies are 531 
warranted to explore the potentials of nutritional strategies using bioactive nutraceuticals 532 
and caloric restriction to control the activation of the NLRP3 inflammasome in CKD patients. 533 
This would fit a broader approach that is gaining increased attention of applying the concept 534 
of “Food as Medicine” using healthy diets - rather than relying only on pharmaceutical 535 
interventions - as an overall strategy to prevent and treat non-communicable chronic burden 536 
of lifestyle diseases including CKD.   537 
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Table 1. Summary of effects of bioactive compounds on chronic kidney disease and renal 1129 
damage markers studies. 1130 
References Samples Intervention Results 
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  In vitro studies  
Ka et al. (2016) 
Murine 
macrophage cell 
lines RAW 264.7 
and J774A.1 
Cinnamaldehyde   
↓ MAPK and PKC-α/δ 
phosphorylation 
↓ ROS, ↓NF-κB activation  
↓ NLRP3 and IL-1β secretion  
Lin et al. (2017) 
 human kidney 
proximal tubular 
epithelial cell line 
HK-2 treated with 
LPS 
4 mg/kg/day of resveratrol for 5 
weeks 
↓expression of NLRP3, ASC, 
caspase-1 and IL-1β 
  In vivo studies (Animals)  
Shan et al. (2014) 
24 male mice with 
kidney injury 
induced by high 
fat diet 
700 mg/kg /day of Purple sweet 
potato color for 20 weeks 
↓ urine albumin-to-creatinine 
ratio 
↓ ROS and AGEs 
↓ expression level of kidney 
NLRP3, ASC, Caspase-1 and 
IL1β 
↓ activation of IKK β and NF-
κB 





Dawley rats with 
subtotal 
nephrectomy 
100 mg/kg/day of theracurmin 
for 5 weeks 
↓ kidney weight 
↓ systolic hypertension 
↓ RNAm expression of NLRP3, 
caspase-1 and IL1β 
Lin et al. (2017) 
 Male C57BL/6 




4 mg/kg/day of resveratrol for 5 
weeks 
↓ serum creatinine and blood 
urea nitrogen 
↓the number of cells that 
expressed NLRP3 
↓expression of NLRP3, ASC, 
caspase-1 and IL-1β 
Ding et al. (2018) 
50 Sprague-
Dawley rats with 
Diabetic 
nephropathy 
100 mg/kg/day of 
Dihydroquercetin for 12 weeks 
↓ urine microalbumin and 
serum creatinine 
↓ LDL-c and total cholesterol 
↓ renal fibrosis, ↓ ROS levels 
↓ protein activations of 
NLRP3, caspase-1 and IL1β 
He et al. (2018) 
30 female mice 
with Lupus 
nephritis 
100 mg/kg/day of procyanidin 
B2 for 8 weeks 
↓ urine protein levels, serum 




↓ NLRP3, ASC, and 
procaspase-1 
↓ renal and serum levels of 
IL-1β and IL-18 
Chen et al. (2019) 
32 male Sprague-
Dawley rats with 
nephropathy 
Injection of resveratrol (30 
mg/kg) 60 min before induction 
of contrast-induced 
↓ serum creatinine and blood 
urea nitrogen 
↓ expression level of renal 
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Abbreviations: LPS: Lipopolysaccharides; I kappa B kinase beta (IKK β);  nuclear translocation of nuclear factor 1131 
kappa beta (NF-κB); Advanced Glycation End-products (AGEs); oxidative stress-associated AGE receptor (RAGE);  1132 
thioredoxin interacting protein  (TXNIP); Reactive oxygen species (ROS); Interleukin (IL); Adaptor Protein Apoptosis-1133 
Associated Speck-Like Protein Containing CARD (ASC); Nod-like receptor pyrin domain containing 3  (NLRP3); protein 1134 
20 (p20); Mitogen Activated Protein Kinases (MAPK); protein kinase C alpha and delta (PKC-α/δ); high sensitivity C-1135 
reactive protein (hsCRP) 1136 
nephropathy NLRP3, caspase-3 and IL1β 
Zhao et al. (2019) 
24 female mice 
with Lupus 
nephritis 
200 mg/kg/day of curcumin for 
8 weeks 
↓ proteinuria and nephritis 
↓ NLRP3 and caspase1 p20 
expression 
↓ IL-1β levels in the kidneys 
  Human studies  
Alvarenga et al. 
(2020) 
28  hemodialysis 
patients 
Control group (n-14): 
Juice with100 mL of orange 
juice with 12 g of carrot after 
each dialysis session/week for 3 
months 
Curcumin group (n-14): 
Juice with 100 mL of orange 
juice with 12 g of carrot and 
2.5 g of turmeric (95%curcumin) 
after each dialysis session/week 
for 3 months 
          Curcumin group: 
↓NF-κB and hsCRP mRNA 
expression 
↔ NLRP3 and IL-1β mRNA 
expression 
